Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 263

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 11
Chunk 263
---

March 2023, the Board amended our director compensation policy to provide that, on the date an individual is first elected or appointed
as a non-employee director, such individual will receive a grant of 25,000 stock options, and that, on the date of each annual meeting
of stockholders, commencing with the annual meeting of stockholders for 2023, each non-employee director (other than the board chair)
will receive a grant of 12,500 stock options and the board chair will receive 30,000 stock options. The initial stock options vest in
over three years from the grant date in equal quarterly installments, subject to continued service on the Board and the options shall
also vest in full immediately upon a director’s death, disability or a change of control. The annual stock options vest in full
on the first anniversary of the grant date, subject to continued service on the Board and the options shall also vest in full immediately
upon a director’s death, disability or a change of control.

90

Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The
following table sets forth certain information with respect to holdings of our common stock by (i) stockholders who beneficially owned
more than 5% of the outstanding shares of our common stock, and (ii) each of our directors (which includes all nominees), each of our
named executive officers and all directors and executive officers as a group as of March 12, 2025, unless otherwise indicated. The number
of shares beneficially owned by each stockholder is determined under rules issued by the SEC. Under these rules, beneficial ownership
includes any shares as to which a person has sole or shared voting power or investment power. Applicable percentage ownership is based
on 14,429,244 shares of common stock outstanding as of March 12, 2025. In computing the number of shares beneficially owned by a person
and the percentage ownership of that person, shares of common stock subject to options, or other rights held by such person that are
currently exercisable or will become exercisable within 60 days of March 12, 2025 are considered outstanding, although these shares are
not considered outstanding for purposes of computing the percentage ownership of any other person.

Unless
otherwise indicated, the address of each beneficial owner listed below is 3 Columbus Circle, 15th Floor, New York, NY 10019.
We believe, based on